Test was first developed to screen blood supplies in Puerto Rico
Abbott’s test is now the first to receive FDA commercial authorisation in an emergency use setting.
US government to provide up to $312 million.
Concerns over collection of test’s supporting data.
A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Companies to collaborate using ‘rational vaccine design’
Inovio and GeneOne Life sciences to begin first-in-human trial.
Test is capable of detecting Zika virus infection directly from blood samples in just 10 to 15 minutes.
A year after Zika virus was confirmed in the Americas, Daniel Ghinn reviews HCP reactions on social media.